| Dr Richard T Kenney, MD | |
|
9917 Conestoga Way, Potomac, MD 20854-4715 | |
| (415) 741-6990 | |
| Not Available |
| Full Name | Dr Richard T Kenney |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 9917 Conestoga Way, Potomac, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942772314 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | D0037459 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard T Kenney, MD 9917 Conestoga Way, Potomac, MD 20854-4715 Ph: (415) 741-6990 | Dr Richard T Kenney, MD 9917 Conestoga Way, Potomac, MD 20854-4715 Ph: (415) 741-6990 |
News Archive
One of four (26%) working-age U.S. adults experienced a gap in health insurance coverage during 2011, often because they lost or changed jobs, according to a new Commonwealth Fund report that also shows how difficult it is for people to regain health insurance on their own after losing employer-sponsored coverage.
The Washington Post examines how the "discovery of an almost untreatable form of tuberculosis [TB] in India has set off alarm bells around the world and helped spur a dramatic expansion of government efforts to battle the killer lung disease."
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive top line results from the pivotal trial of single agent brentuximab vedotin (SGN-35), an antibody drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can't reach? Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk. The research appeared as a communication in the February 10 edition of the Journal of the American Chemical Society.
› Verified 4 days ago
Dr. Mario O Belledonne, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8200 Tuckerman Ln, Potomac, MD 20854 Phone: 301-605-7878 Fax: 301-605-7878 | |
Dr. Tatiana Oussova, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 11929 Glen Mill Rd, Potomac, MD 20854 Phone: 301-437-4873 | |
Rajaa Nahra, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 10005 S Glen Rd, Potomac, MD 20854 Phone: 603-557-8446 | |
Dr. Kok-seah Lee, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 9509 Newbridge Dr, Potomac, MD 20854 Phone: 703-868-1311 | |
Dr. Mark Goldberger, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 10001 Ormond Rd, Potomac, MD 20854 Phone: 301-983-1003 | |
Dr. Audrey Chan Ho, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 10409 Shepherds Crook Ct, Potomac, MD 20854 Phone: 610-725-0435 | |
Dr. Stephen Fredd, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1907 Sunrise Dr, Potomac, MD 20854 Phone: 301-340-2216 |